CXCR3 Blocking Peptide for STJ500655 peptide (STJ505277)

SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 1-50 on human CXCR3 protein
STJ505277-250
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionCXCR3 Blocking Peptide for STJ500655 is synthetically produced from the 1-50 sequence and is suitable for use in western blot applications.
ApplicationsImmunodepletion/Immunocompetition
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

FormulationLiquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage InstructionStore at-20°C for long term storage. Avoid freeze-thaw cycles.

Target Information

Gene SymbolCXCR3
Gene ID2833
Uniprot IDCXCR3_HUMAN
ImmunogenSynthetic peptide taken within amino acid region 1-50 on human CXCR3 protein
Immunogen Region1-50
SpecificityThis blocking peptide is recommended for use in combination with CXCR3 antibody, STJ500655

Additional Info

Post Translational Modifications Sulfation on Tyr-27 and Tyr-29 is essential for CXCL10 binding and subsequent signal transduction induction. N-glycosylated.
Function Isoform 1: Receptor for the C-X-C chemokine CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of human mesangial cells (HMC) through a heterotrimeric G-protein signaling pathway. Binds to CCL21. Probably promotes cell chemotaxis response. Upon activation by PF4, induces activated T-lymphocytes migration mediated via downstream Ras/extracellular signal-regulated kinase (ERK) signaling. Isoform 2: Receptor for the C-X-C chemokine CXCL4 and also mediates the inhibitory activities of CXCL9, CXCL10 and CXCL11 on the proliferation, survival and angiogenic activity of human microvascular endothelial cells (HMVEC) through a cAMP-mediated signaling pathway. Does not promote cell chemotaxis respons. Interaction with CXCL4 or CXCL10 leads to activation of the p38MAPK pathway and contributes to inhibition of angiogenesis. Overexpression in renal cancer cells down-regulates expression of the anti-apoptotic protein HMOX1 and promotes apoptosis. Isoform 3: Mediates the activity of CXCL11.
Peptide Name C-X-C Chemokine Receptor Type 3
Cxc-R3
Cxcr-3
Ckr-L2
G Protein-Coupled Receptor 9
Interferon-Inducible Protein 10 Receptor
Ip-10 Receptor
Cd Antigen Cd183
Database Links Reactome: R-HSA-380108
Reactome: R-HSA-418594
Cellular Localisation Isoform 1: Cell Membrane
Multi-Pass Membrane Protein
Isoform 2: Cell Membrane
Alternative Peptide Names C-X-C Chemokine Receptor Type 3 protein
Cxc-R3 protein
Cxcr-3 protein
Ckr-L2 protein
G Protein-Coupled Receptor 9 protein
Interferon-Inducible Protein 10 Receptor protein
Ip-10 Receptor protein
Cd Antigen Cd183 protein
CXCR3 protein
GPR9 protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins